“…Although the results of early studies were optimistic, with better than predicted outcomes in treated patients, a further case series was less promising 226. Case reports have also described the outcome of patients with severe AH treated with leukocytapharesis after failing to improve substantially on steroids 227, 228. These reports are promising, but recommendations regarding their appropriate use must await results of comparative studies of outcomes in these patients.…”
“…Although the results of early studies were optimistic, with better than predicted outcomes in treated patients, a further case series was less promising 226. Case reports have also described the outcome of patients with severe AH treated with leukocytapharesis after failing to improve substantially on steroids 227, 228. These reports are promising, but recommendations regarding their appropriate use must await results of comparative studies of outcomes in these patients.…”
“…Each patient had received up to five GMA sessions, at one or two sessions/week as a basic treatment course. Given that neutrophils are the major components of elevated WBC counts 25,28–30 and that GMA selectively depletes myeloid linage leucocytes, 26,27 the survival rates seen in this figure clearly show that: (a) high neutrophil count in SAH is pathologic and (b) depleting neutrophils/monocytes has a significant affect on the prognosis. Therefore, the results strongly favored GMA (albeit the sample size was small in this retrospective study).…”
Our perception is that, patients with elevated myeloid leucocytes benefit most from GMA, while plasma exchange appears to support patients with coagulation deficiency or high plasma bilirubin and HD has indication in patients with high Cr.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.